Long-Cheng LI is the founder of Ractigen Therapeutics. Ractigen Therapeutics has raised $80M in total funding. Latest round: Series A.
Long-Cheng Li is the Co-founder, President, and CEO of Ractigen Therapeutics, a clinical-stage biotech company focused on developing small activating RNA (saRNA) therapeutics. He leads the company's efforts to advance saRNA programs from preclinical to clinical phases.
Full founder directory · Investor directory · Company funding database · Fundraising library